[
  {
    "ts": null,
    "headline": "4 Stocks That Accelerated Growth In Its Smaller, But Higher Margin Segments",
    "summary": "Upslope Capital's Q4 2025 letter details new positions in Booz Allen Hamilton and Crown Holdings amid shifting macro conditions. Read the full investment thesis now.",
    "url": "https://finnhub.io/api/news?id=425daff74a83c44698d2a7a2f7a5eab22057e4678648971dcafa78203d81f533",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768345200,
      "headline": "4 Stocks That Accelerated Growth In Its Smaller, But Higher Margin Segments",
      "id": 138090035,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2221411629/image_2221411629.jpg?io=getty-c-w1536",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "Upslope Capital's Q4 2025 letter details new positions in Booz Allen Hamilton and Crown Holdings amid shifting macro conditions. Read the full investment thesis now.",
      "url": "https://finnhub.io/api/news?id=425daff74a83c44698d2a7a2f7a5eab22057e4678648971dcafa78203d81f533"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Analysts See a 26.42% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High?",
    "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 26.4% in West Pharmaceutical (WST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.",
    "url": "https://finnhub.io/api/news?id=9c19064cf1fd5b89cf292b96cf31953fe4b742cfc03aaac39f1e60b41f76186f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768316102,
      "headline": "Wall Street Analysts See a 26.42% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High?",
      "id": 138087031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 26.4% in West Pharmaceutical (WST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.",
      "url": "https://finnhub.io/api/news?id=9c19064cf1fd5b89cf292b96cf31953fe4b742cfc03aaac39f1e60b41f76186f"
    }
  }
]